Greg Christie
Chief Product Officer
StudyKIK
Purpose-Driven Tech that Enhances Lives
As Chief Product Officer at StudyKIK, a Syneos Health company, Greg Christie serves as a transformative leader who spends most of his time thinking about, redefining, and improving the clinical trial process. He demonstrates a remarkable empathy and passion for creating technologies that benefit both patients and the research community. Driven by a mission to transform the study experience, Greg has established a culture of patient-centered product development that puts patients at the forefront of the development journey.
Among his team’s latest innovations are patient mobile applications, a management portal that simplifies operations for research sites, and an informative analytics dashboard for sponsors. With a unique ability to understand user needs, Greg has led the development of clinical trial technologies that are not only effective, but also intuitive for use at patient, site, and sponsor levels.
A recent oncology research study application won the prestigious Summit for Clinical Ops Executives (SCOPE) Participant Engagement Award. The application was developed with patients and provides unprecedented insight into their treatment journey. From the beginning of their trial to its conclusion, patients can track their progress, while caregivers remain informed and connected. It improves patient knowledge, encourages a better relationship with caregivers, and provides robust data.
With an inspiring leadership style, Greg actively fosters a culture of inclusivity and collaboration, where everyone’s input is valued and considered. As attested by his team, his approach to leadership encourages open communication, resulting in highly motivated and dedicated participants committed to developing innovative and impactful solutions.
In summary, Greg is a visionary leader with a profound desire to identify and develop next-generation technologies that are indispensable in clinical research, all while keeping the user experience at the forefront. He is the embodiment of a Tech-Know Geek who is sure to have a huge impact on the lives of everyone involved in clinical trials.
